From that point onwards, there was a massive, concerted effort to shift media narratives to encourage mass infection, supposedly as a pro-business move.
Predictably, that was a disastrous decision in terms of public health outcomes.
Anyone who has seriously followed the research on COVID will tell you that the risk of myocarditis (among numerous other conditions) from COVID is far greater than that of Novavax.
The 3CL protease, a critical part of the viral machinery that allows SARS-CoV-2 to replicate, binds with hundreds of proteins in the liver and gut alone.
This will be the first time Novavax is available outside of Emergency Use Authorization.
Getting access to it this year may require a bit of extra effort, since the new license stipulates that most must have an underlying condition to access the vaccine.